{
    "2018-04-03": [
        [
            {
                "time": "",
                "original_text": "东吴医药行业周观点：药明康德成为第二家“IPO快速通道”的独角兽公司 创新药主题迎来新一轮投资机会",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO快速通道",
                        "独角兽",
                        "创新药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 医药生物行业深度研究：医药市场认可提升 优选高景气子行业龙头",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "市场认可",
                        "高景气",
                        "子行业龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级] 医药生物行业投资策略：从工业数据窥见医药行业配置意义与投资价值",
                "features": {
                    "keywords": [
                        "强于大市评级",
                        "医药生物",
                        "投资策略",
                        "工业数据",
                        "配置意义",
                        "投资价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}